Fundsmith ADMA trades
Terry Smith
Terry Smith ADMA Biologics Inc stake
total: 91
Trades details
- Total transactions:
- 2
- New positions:
- 1
- Reduced:
- 1
- Held since:
- 2025 Q4
- Held for:
- 3 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q2 report, Terry Smith holds 1,649,493 ADMA Biologics Inc (ADMA) shares with a market value of roughly $13.81M accounting for 0.10% of the overall portfolio. To date, the estimated cost basis is nearly $18.24 for "buy" trades and estimated average "sell" price is $9.01. Fundsmith first purchased ADMA in 2025 Q4, initially acquiring about 2.10M shares. Since the initial investment in ADMA Biologics Inc (ADMA), Fundsmith has made 1 more transaction.
When did Terry Smith buy ADMA Biologics Inc (ADMA)?
Terry Smith first invested in ADMA Biologics Inc (ADMA) in 2025 Q4 at the reported quarter-end price of $18.24 per share.
What's the cost basis of Fundsmith's ADMA stake?
The estimated cost basis for ADMA Biologics Inc (ADMA) stake is around $18.24 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $18.24
- Weighted AVG sell price:
- $9.01
Terry Smith's historical trades in ADMA Biologics Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.12%
|
1,649,493
|
$9.01
|
$14,861,932
|
-21.53% (-452,561)
|
-0.02%
|
|
2025 Q4
|
0.22%
|
2,102,054
|
$18.24
|
$38,341,465
|
new
|
+0.22%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.